ADD CONDITION

items per page

Cvs Anti-Itch Hydrocortisone

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Hydrocortisone 1 mg/1 g
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2014
Label revision date
September 12, 2016
Active ingredient
Hydrocortisone 1 mg/1 g
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2014
Label revision date
September 12, 2016
Manufacturer
CVS Pharmacy, Inc.
Registration number
part348
NDC root
59779-844

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

You may be looking for a treatment that can be applied to specific areas of the skin. This medication is designed to be used on affected areas, and you can apply it up to three to four times a day. It is important to consult a doctor if you are considering using it for children under 2 years of age.

This product is intended to help manage certain skin conditions, providing relief and support for your skin's health. Always follow the guidance of a healthcare professional to ensure safe and effective use.

Uses

You can use this medication to treat specific skin conditions by applying it to the affected area. It's important to limit the application to no more than 3 to 4 times a day for the best results. If you have a child under 2 years old, please consult a doctor before using this product.

Rest assured, there are no known teratogenic effects (which means it doesn't cause birth defects) or nonteratogenic effects associated with this medication. Always follow the guidance provided for safe and effective use.

Dosage and Administration

It seems that there is no specific dosage or administration information available for the medication you are inquiring about. This means that details such as how much to take, how often to take it, or how to apply it are not provided.

If you have any questions about how to use this medication or need guidance on its administration, it's best to consult with your healthcare provider or pharmacist. They can give you the most accurate and personalized information based on your health needs.

What to Avoid

It's important to be aware of certain precautions when using this product. You should avoid using it in or near your eyes, as this can cause irritation or harm. Additionally, if you're considering using it for diaper rash, please consult a doctor first to ensure it's appropriate for your situation.

While there are no specific contraindications or concerns about abuse, misuse, or dependence associated with this product, following these guidelines will help ensure your safety and well-being. Always prioritize your health by using medications as directed.

Side Effects

When using this product, it's important to remember that it is for external use only. If your condition worsens or if symptoms persist for more than 7 days, you should stop using the product and consult a doctor. Additionally, if your symptoms clear up and then return within a few days, it's advisable to seek medical advice.

If you are currently using any other hydrocortisone product, please consult with a doctor before using this one. There are no specific adverse reactions or side effects mentioned, but staying informed and cautious is always a good practice.

Warnings and Precautions

This product is for external use only, so please avoid using it on any internal areas of your body. It's important to keep it out of reach of children. If a child accidentally swallows it, seek medical help or contact a Poison Control Center immediately.

You should stop using this product and consult your doctor if your condition worsens, if symptoms persist for more than 7 days, or if symptoms improve and then return within a few days. Always prioritize your health and safety by following these guidelines.

Overdose

If you suspect an overdose, it’s important to act quickly. Signs of an overdose can vary, but they may include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these symptoms, seek immediate medical help.

In the event of an overdose, contact your local emergency services or go to the nearest hospital. It’s crucial to provide them with as much information as possible about the substance taken and the amount, if known. Remember, your safety is the top priority, so don’t hesitate to get help.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that the safety of hydrocortisone during pregnancy has not been established. You should consult your doctor before using this medication, as there may be potential risks to your fetus that are not clearly defined.

While there are no specific dosage modifications for pregnant individuals, it's crucial to seek guidance from a healthcare professional regarding your treatment options. Always prioritize open communication with your doctor to ensure the best care for you and your baby.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Additionally, there are no known concerns about the product being passed into breast milk or any associated risks for your infant. This means you can use the product without worrying about its effects on your milk production or your baby's health.

Pediatric Use

If you have a child under 2 years old, it's important to consult a doctor before using this medication. For all children, make sure to keep the medication out of their reach. If your child accidentally swallows it, seek medical help or contact a Poison Control Center immediately. Your child's safety is the top priority, so always follow these guidelines closely.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment is safe and effective for your specific condition. They can help you understand any necessary precautions or adjustments based on your kidney health.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your liver health. They can help monitor your condition and make any necessary adjustments to your treatment plan.

Drug Interactions

It's important to talk to your healthcare provider before using this medication, especially if you are already using any other hydrocortisone products. Combining different hydrocortisone treatments can lead to unexpected side effects or reduce the effectiveness of your treatment.

Always keep your doctor informed about all the medications and products you are using to ensure your safety and the best possible care.

Storage and Handling

To ensure the best performance of your product, store it at room temperature. It's important to keep it away from freezing temperatures and excessive heat, as these conditions can affect its effectiveness.

When handling the product, always do so with care to maintain its integrity. Following these simple storage and handling guidelines will help ensure that you use the product safely and effectively.

Additional Information

You should apply the medication topically to the affected area, using it no more than 3 to 4 times a day. This means you can put it on the skin where you need treatment, but be careful not to overuse it. If you have any questions about how to use the medication or its effects, consult your healthcare provider for guidance.

FAQ

How should I apply this medication?

You should apply it to the affected area no more than 3 to 4 times daily.

Is this medication safe for children under 2 years?

No, do not use this medication for children under 2 years without consulting a doctor.

What should I do if my condition worsens?

Stop use and ask a doctor if your condition worsens or if symptoms persist for more than 7 days.

Can I use this medication if I am pregnant?

Consult a doctor before use if you are pregnant or planning to become pregnant, as the safety during pregnancy has not been established.

What should I do if I accidentally swallow this medication?

If swallowed, get medical help or contact a Poison Control Center right away.

Are there any specific warnings for this medication?

Yes, it is for external use only and should not be used in or near the eyes.

What if I am using another hydrocortisone product?

Ask a doctor before use if you are using any other hydrocortisone product.

How should I store this medication?

Store at room temperature and protect from freezing and excessive heat.

Packaging Info

Below are the non-prescription pack sizes of Cvs Anti-Itch Hydrocortisone (hydrocortisone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Cvs Anti-Itch Hydrocortisone.
Details

Drug Information (PDF)

This file contains official product information for Cvs Anti-Itch Hydrocortisone, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for topical application to the affected area, with a recommended frequency of no more than 3 to 4 times daily.

Limitations of Use: This drug is not recommended for use in children under 2 years of age unless directed by a healthcare professional.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

No dosage and administration information is available for this product. Healthcare professionals are advised to consult the prescribing information or relevant clinical guidelines for specific dosing recommendations and administration techniques.

Contraindications

Use of this product is contraindicated in the following situations:

The product should not be applied in or near the eyes due to the potential for irritation or adverse effects. Additionally, it is contraindicated for use on diaper rash; consultation with a healthcare professional is advised in such cases.

Warnings and Precautions

For external use only. It is imperative that this product is kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Healthcare professionals should advise patients to discontinue use and consult a physician if the condition worsens or if symptoms persist beyond 7 days. Additionally, if symptoms resolve and then recur within a few days, patients should also seek medical advice.

In cases of ingestion, it is crucial to obtain emergency medical help or contact a Poison Control Center immediately.

Side Effects

For external use only. Patients should discontinue use and consult a doctor if the condition worsens or if symptoms persist for more than 7 days. Additionally, if symptoms last more than 7 days or clear up and then recur within a few days, medical advice should be sought.

Patients are advised to ask a doctor before using this product if they are currently using any other hydrocortisone product. No specific adverse reactions or side effects have been identified in the available data.

Drug Interactions

Concurrent use of hydrocortisone with other hydrocortisone-containing products should be approached with caution. It is advisable for patients to consult a healthcare professional prior to using multiple hydrocortisone formulations. This is to prevent potential additive effects and to ensure appropriate management of dosage and treatment duration. Monitoring for signs of excessive corticosteroid exposure may be warranted in such cases.

Packaging & NDC

Below are the non-prescription pack sizes of Cvs Anti-Itch Hydrocortisone (hydrocortisone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Cvs Anti-Itch Hydrocortisone.
Details

Pediatric Use

Pediatric patients under 2 years of age should not use this medication without consulting a healthcare professional. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of hydrocortisone during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare professional before use. While potential risks to the fetus are not clearly defined, caution is advised when considering the use of this medication during pregnancy. There are no specific dosage modifications for pregnant individuals; therefore, it is essential to seek guidance from a healthcare professional regarding appropriate use in this population.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific details regarding overdosage for this medication (SPL code 34088-5), it is essential for healthcare professionals to remain vigilant and consider general principles of management in cases of suspected overdose.

Recommended Actions In the event of an overdose, immediate medical attention should be sought. Healthcare providers are advised to assess the patient's clinical status and initiate supportive care as necessary. Monitoring vital signs and providing symptomatic treatment may be required based on the patient's condition.

Potential Symptoms While specific symptoms of overdosage are not detailed, healthcare professionals should be aware that overdose may lead to a range of adverse effects. These can vary widely depending on the pharmacological properties of the medication involved. It is crucial to evaluate the patient for any signs of toxicity or adverse reactions.

Management Procedures Management of an overdose should be tailored to the individual patient and may include decontamination procedures, such as activated charcoal, if appropriate and within the timeframe of ingestion. Supportive care, including intravenous fluids and monitoring of organ function, may also be necessary. Consultation with a poison control center or a medical toxicologist is recommended for guidance on specific interventions and antidotes, if applicable.

In summary, while specific overdosage information is not provided, healthcare professionals should be prepared to act swiftly and effectively in the event of an overdose, utilizing general principles of emergency care and supportive management.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that the medication is not intended for use in or near the eyes and should not be used for diaper rash without consulting a doctor. It is important to instruct patients to discontinue use and consult a healthcare professional if their condition worsens or if symptoms persist for more than 7 days. Additionally, patients should be advised to stop using the medication and seek medical advice if symptoms last longer than 7 days or if they resolve and then recur within a few days.

Finally, healthcare providers should recommend that patients consult a doctor before using this medication if they are currently using any other hydrocortisone product to avoid potential interactions.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, ensuring that it is protected from freezing and excessive heat to maintain its integrity and efficacy. Proper handling and storage conditions are crucial for preserving the quality of the product throughout its shelf life.

Additional Clinical Information

The medication is administered topically, with application to the affected area recommended no more than 3 to 4 times daily. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Cvs Anti-Itch Hydrocortisone, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Cvs Anti-Itch Hydrocortisone, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.